Literature DB >> 28405739

Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees.

N Zander1, I Schäfer2, M Radtke2, A Jacobi2, H Heigel3, M Augustin2.   

Abstract

The field of dermatological comorbidity in psoriasis is only passively explored with contradictory results. Objective of this study was to further investigate the complex field of psoriasis and associated skin diseases by identifying skin comorbidity patterns in an extensive cohort of employees in Germany. Retrospective analysis of data deriving from occupational skin cancer screenings was conducted. From 2001 to 2014 German employees between 16 and 70 years from different branches underwent single whole-body screenings by trained dermatologists in their companies. All dermatological findings and need for treatment were documented. Point prevalence rates and their 95% confidence intervals were computed. Logistic regression analysis was performed to calculate odds ratios (OR) of single dermatological diseases to occur together with psoriasis controlled for age and sex. Data from 138,930 persons (56.5% male, mean age 43.2) were evaluated. Psoriasis point prevalence was 2.0%. Of those 20.6% had unmet treatment needs of their disease. Onychomycosis was the most frequent dermatological comorbidity with a prevalence of 7.8%. Regression analysis found rosacea (OR = 1.40, 95% CI 1.13-1.72) and telangiectasia (OR = 1.25, 95% CI 1.10-1.41) to be significantly associated with psoriasis. 17.2% of psoriasis patients had at least one further finding requiring treatment. The highest treatment needs were found for onychomycosis (3.4%), tinea pedis (3.1%), and verruca plantaris (1.0%). It can be concluded that persons with psoriasis are at increased risk to suffer from comorbid skin diseases, which should be considered in treatment regimens. Particular attention should be paid to fungal diseases of the feet.

Entities:  

Keywords:  Comorbidities; Epidemiology; Need for treatment; Prevalence rates; Psoriasis

Mesh:

Year:  2017        PMID: 28405739     DOI: 10.1007/s00403-017-1741-4

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Case Report: Successful Treatment of Chromoblastomycosis Caused by Fonsecaea monophora in a Patient with Psoriasis Using Itraconazole and Acitretin.

Authors:  Fangfang Bao; Qihua Wang; Changping Yu; Panpan Shang; Lele Sun; Guizhi Zhou; Mei Wu; Furen Zhang
Journal:  Am J Trop Med Hyg       Date:  2018-05-17       Impact factor: 2.345

Review 2.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

3.  Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands.

Authors:  Candan Kendir; Marjan van den Akker; Rein Vos; Job Metsemakers
Journal:  Eur J Gen Pract       Date:  2017-11-23       Impact factor: 1.904

Review 4.  Digestive system in psoriasis: an update.

Authors:  Daniel Pietrzak; Aldona Pietrzak; Dorota Krasowska; Andrzej Borzęcki; Kinga Franciszkiewicz-Pietrzak; Beata Polkowska-Pruszyńska; Maja Baranowska; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2017-09-13       Impact factor: 3.017

5.  Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.

Authors:  Leena Chularojanamontri; Penvadee Pattanaprichakul; Charussri Leeyaphan; Panittra Suphatsathienkul; Supisara Wongdama; Sumanas Bunyaratavej
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

6.  Regional variations and prevalence of psoriasis in Germany from 2010 to 2017: a cross-sectional, spatio-epidemiological study on ambulatory claims data.

Authors:  Valerie Andrees; Sandra Wolf; Matthias Augustin; Nicole Mohr; Jobst Augustin
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

7.  Epidemiology of Vitiligo - A Dual Population-Based Approach.

Authors:  Nicole Mohr; Jana Petersen; Natalia Kirsten; Matthias Augustin
Journal:  Clin Epidemiol       Date:  2021-05-26       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.